NSEESOP/ESOS/ESPS30 Jul 2026 · 30 Jul 2026, 02:58 pm
ESOP/ESOS/ESPS
Eris Lifesciences Limited · ERIS
✦ AI SummaryESG
Eris Lifesciences Limited has informed the Exchange regarding the allotment of 4816 shares under the ESOP-2017 Scheme, increasing the company's paid-up share capital from Rs. 13,85,78,489 to Rs. 13,85,83,305.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eris Lifesciences Limited has informed the Exchange regarding Allotment of 4816 Shares.
Attachments (1)
📄pdf
Download →
ERIS_30072026145739_intimationsigned.pdf
View document text
Date: 30 July 2026
To To
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza
Dalal Street Bandra Kurla Complex
Mumbai- 400001 Bandra (E)
Mumbai-400051
Security Code: 540596 Symbol: ERIS
Dear Sir/Madam,
SUB: ALLOTMENT OF EQUITY SHARES PURSUANT TO ESOP-2017 SCHEME
It is hereby informed that an allotment of 4,816 equity shares of Re. 1/- each at a premium of Rs. 450.04/- per
share has been made on July 30, 2026, pursuant to the exercise of options under the ESOP-2017 Scheme.
The paid-up share capital of the Company accordingly stands increased from Rs. 13,85,78,489/-
(13,85,78,489 equity shares of Re. 1/- each) to 13,85,83,305/- (13,85,83,305 equity shares of Re. 1/- each).
The Information may please be taken on records.
Thanking You.
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
ICSI Mem. No.: A26493